News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
OraSure Technologies, Inc. Settles Suit with Inverness Medical Innovations, Inc., Sees Wider Q4 Loss
November 19, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- OraSure Technologies Inc said it settled patent litigation related to certain HIV products with Inverness Medical Innovations Inc (IMA.N) and Church & Dwight Co Inc (CHD.N) and agreed to pay Inverness a sum of $3 million in cash.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Manufacturing
Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program
July 1, 2026
·
2 min read
·
Nick Paul Taylor
FDA
BIO 2026: FDA’s IND initiative is a step toward normalization after slipshod year
June 25, 2026
·
3 min read
·
Jef Akst
Duchenne muscular dystrophy
REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy
June 24, 2026
·
2 min read
·
Gabrielle Masson
Policy
BIO 2026: US public health as we know it is gone. Can we rebuild a better system?
June 23, 2026
·
4 min read
·
Jef Akst